Isolated limb perfusion with the tumor-targeting human monoclonal antibody-cytokine fusion protein L19-TNF plus melphalan and mild hyperthermia in patients with locally advanced extremity melanoma

20 Years Experience of TNF-Based Isolated Limb Perfusion for In-Transit Melanoma Metastases: TNF Dose Matters

(2011) Jan P. Deroose et al.   ANNALS OF SURGICAL ONCOLOGY

Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases

(2011) J. P. Deroose et al.   BRITISH JOURNAL OF SURGERY

Isolated limb perfusion for melanoma in-transit metastases: developments in recent years and the role of tumor necrosis factor alpha

(2010) Jan P Deroose et al.   CURRENT OPINION IN ONCOLOGY

Isolated Limb Perfusion for Malignant Melanoma: Systematic Review on Effectiveness and Safety

(2010) D. Moreno-Ramirez et al.   ONCOLOGIST

Expression of the oncofetal ED-B-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients

(2009) S. Sauer et al.   BLOOD

Isolated Limb Perfusion for Melanoma

(2008) Bin B.R. Kroon et al.   Surgical Oncology Clinics of North America